Chinese pharma firms Joyo, Zion secure Series B funding

Photo: Getty Images Pro via DealStreetAsia

Joyo Pharma has secured over 300 million yuan ($46 million) in its Series B round while OrbiMed Healthcare Fund Management has led the $40-million Series B funding in Zion Pharma. 

Joyo Pharma nabs over $46m in Series B 

Innovative drugs maker Joyo Pharma on Wednesday announced that it has bagged over 300 million yuan ($46 million) in its Series B round jointly led by Sequoia Capital China and state-owned SDIC Venture Capital. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter